Linkage disequilibrium between IDUA kpnI-VNTR haplotype in Mexican patients with MPS-I

M Gallegos-Arreola1, F Rivas-Solis, S Flores-Martínez

  • 1División de Medicina Molecular, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico. marthaga@foreigner.class.udg.mx

Abstract

Insights

Mucopolysidosis type I (MPS-I) genetic origins in Mexico may stem from Spanish introductions, predating European ancestral dispersion. Differences in MPS-I genetic disequilibrium between Mexican and Australian populations are attributed to genetic drift.

Area of Science:

  • Genetics
  • Population Genetics
  • Biochemistry

Background:

  • Mucopolysidosis type I (MPS-I) is an autosomal recessive disorder caused by mutations in the IDUA gene, leading to a deficiency in alpha-L-iduronidase.
  • This enzyme deficiency impairs the degradation of heparan and dermatan sulfate, resulting in a wide spectrum of clinical symptoms.

Purpose of the Study:

  • To investigate intragenic polymorphisms (KpnI and VNTR) within the IDUA gene in Mexican mestizo and Huichol Indian populations.
  • To compare these findings with MPS-I patients and normal individuals from Mexico and Australia to understand the genetic origins and population dynamics of MPS-I.

Main Methods:

  • Genotyping for KpnI (K) and VNTR (V) polymorphisms in the IDUA gene was performed on Mexican mestizo, Huichol Indian, and Australian populations.
  • Haplotype frequency distributions (HFDs) were analyzed and compared between normal and MPS-I affected individuals from both regions.

Main Results:

  • IDUA gene K-V haplotype frequency distributions differed significantly between normal Mexican and Australian populations.
  • Mexican MPS-I patients exhibited distinct HFDs compared to normal Mexican groups, suggesting linkage disequilibrium between K-V polymorphisms and MPS-I mutations.
  • Haplotype frequencies in Mexican MPS-I patients differed from those in Australian MPS-I patients, with specific haplotypes (K2-V1, K1-V3) increased or decreased in Mexicans, and others (K2-V2, K1-V2) in Australians.

Conclusions:

  • Similar HFDs between Mexican and Australian MPS-I patients suggest a common genetic origin, likely introduced to Mexico via Spanish colonization.
  • The observed mutations predate the dispersion between Mexican and Australian Caucasian ancestors.
  • Differences in linkage disequilibrium patterns are attributed to genetic drift within the respective populations.

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...